Schedule 13D ownership disclosure
CHECKPOINT THERAPEUTICS INC
Security class unavailable · CUSIP: 162828206
Event date: 2023-01-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-003819
- Form type
- SC 13D
- Filer
- Checkpoint Therapeutics, Inc.
- CIK
- CIK 1651407
- Filed
- Jan 13, 2023
- Reporting period
- Jan 05, 2023
- Description
- Schedule 13D beneficial ownership